PD-L1-expressing cancer-associated fibroblasts induce tumor immunosuppression and contribute to poor clinical outcome in esophageal cancer.
Kawasaki K, Noma K, Kato T, Ohara T, Tanabe S, Takeda Y, Matsumoto H, Nishimura S, Kunitomo T, Akai M, Kobayashi T, Nishiwaki N, Kashima H, Maeda N, Kikuchi S, Tazawa H, Shirakawa Y, Fujiwara T.
Kawasaki K, et al. Among authors: nishimura s.
Cancer Immunol Immunother. 2023 Nov;72(11):3787-3802. doi: 10.1007/s00262-023-03531-2. Epub 2023 Sep 5.
Cancer Immunol Immunother. 2023.
PMID: 37668710
Free PMC article.